Literature DB >> 2473711

Lack of activity of fusidic acid against human immunodeficiency virus in monocytes.

T Maehlen1, M Degré.   

Abstract

The effect of fusidic acid on the multiplication of human immunodeficiency virus in monocyte-derived macrophages was examined in in vitro cultures. Virus titers, measured by reverse transcriptase and by p24 antigen in the supernatants and in lysed cells, were reduced in some experiments by 50 micrograms/ml or more; in other experiments, 10 micrograms of fusidic acid per ml added to the cells simultaneously with the virus inoculation reduced virus titers. The effect was comparable in peripheral blood lymphocytes. The drug was generally toxic to the cells, both macrophages and peripheral blood lymphocytes, in concentrations of 50 micrograms/ml or more.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473711      PMCID: PMC172513          DOI: 10.1128/AAC.33.5.680

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Micromethod for assaying reverse transcriptase of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  T J Spira; L H Bozeman; R C Holman; D T Warfield; S K Phillips; P M Feorino
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

2.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

3.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

4.  Inhibition of HIV replication in vitro by fusidic acid.

Authors:  V Faber; A G Dalgleish; A Newell; M Malkovsky
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

5.  Infection of monocyte/macrophages by human T lymphotropic virus type III.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies.

Authors:  M A Talle; P E Rao; E Westberg; N Allegar; M Makowski; R S Mittler; G Goldstein
Journal:  Cell Immunol       Date:  1983-05       Impact factor: 4.868

7.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

8.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions.

Authors:  A D Hoffman; B Banapour; J A Levy
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

9.  Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.

Authors:  J C Unkeless; H N Eisen
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen.

Authors:  G Kaplan; G Gaudernack
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Impaired in vitro survival of monocytes from patients with HIV infection.

Authors:  F Müller; H Rollag; G Gaudernack; S S Frøland
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects.

Authors:  F Müller; H Rollag; S S Frøland
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.